1983
DOI: 10.1016/s0021-9258(18)33011-4
|View full text |Cite
|
Sign up to set email alerts
|

Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

1984
1984
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 110 publications
(8 citation statements)
references
References 43 publications
0
8
0
Order By: Relevance
“…This is certainly true if we assume that oxytocin given intranasally reaches its receptors in the brain intact. This point is difficult to prove, and it is well known that oxytocin may be rapidly metabolized by the peptidases present in blood [ 328 ] as well as in brain tissues (see [ 329 , 330 , 331 ]) to oxytocin fragments that are devoid of typical oxytocin bioactivity or that induce effects that are different from those induced by intact oxytocin (see [ 63 , 330 , 331 ] and references therein). This raises the possibility that many of the effects reported after intranasal oxytocin administration are due to some of its fragments not acting on or that are acting on sites that are different from the oxytocin receptor sites.…”
Section: Final Remarksmentioning
confidence: 99%
“…This is certainly true if we assume that oxytocin given intranasally reaches its receptors in the brain intact. This point is difficult to prove, and it is well known that oxytocin may be rapidly metabolized by the peptidases present in blood [ 328 ] as well as in brain tissues (see [ 329 , 330 , 331 ]) to oxytocin fragments that are devoid of typical oxytocin bioactivity or that induce effects that are different from those induced by intact oxytocin (see [ 63 , 330 , 331 ] and references therein). This raises the possibility that many of the effects reported after intranasal oxytocin administration are due to some of its fragments not acting on or that are acting on sites that are different from the oxytocin receptor sites.…”
Section: Final Remarksmentioning
confidence: 99%
“…The peptide used in this study, AVP 4–9 , is an endogenous metabolite of vasopressin produced by proteolysis in various brain regions (Burbach & Lebouille, 1983). Unlike VP, systemic administration of this peptide is not aversive to rats at behaviorally active doses (A. Ettenberg, personal communication, November 1986).…”
mentioning
confidence: 99%
“…The oxytocin molecule has a very short half-life (3–6 min in the periphery and 19 min in the CNS) [ 140 , 141 ]. It is quickly degraded by multiple peripheral and brain aminopeptidases [ 142 , 143 , 144 ] and its baseline circulating levels in non-pregnant/non-lactating individuals are very low (<8 pg/mL) [ 145 ]. In addition to these inherent characteristics, the major challenge relating to the research of endogenous oxytocin levels is the lack of standardized measurement techniques.…”
Section: Observational Studies In Humans-relation Of Oxytocin To Food Intake Weight Status and Metabolismmentioning
confidence: 99%